OvaGene Oncology is a molecular diagnostics company dedicated to improving women's health through the development of innovative molecular assays designed to assist physicians in caring for their patients with gynecologic disorders. OvaGene‘s unique gynecologic tumor assays provide personalized drug response profiles to aid in therapy selection including chemotherapy, radiation, and targeted agents. In addition to the drug response profiles, OvaGene has a rich pipeline of proprietary products currently in development by our in-house research team for future commercialization.